Canada is a high-income country with a population of 33 million. Life expectancy is high
compared with most OECD countries; however, infant and maternal mortality rates tend to be …

Pharmaceutical expenditure is rising globally. Most high-income countries have exercised
pricing or purchasing strategies to address this pressure. Low-and middle-income countries …

The health care system in Canada receives a great deal of international attention, but it is
subject to considerable critique and debate locally. Health Systems in Transition: Canada …

Background The use of a restrictive formulary, with placement determined through a drug-
reimbursement decision-making process, is one approach to managing drug expenditures …

This paper examines aspects of the policy environment and market characteristics of the
Swedish pharmaceutical sector, assesses the degree to which Sweden has achieved …

Background Publicly-funded drug plans vary in strategies used and policies employed to
reduce continually increasing pharmaceutical expenditures. We systematically reviewed the …

Objectives To characterize at a global level the concept of therapeutic value (TV) and
describe the experience of value-based pricing (VBP) policies in 6 reference countries …

Over the past 10 years there has been increased recognition of the importance of publicity
as a means of generating product awareness. Despite this, previous research has seldom …

2010. Based on conservative hypotheses, the report showed that a public and universal
drug plan based on first-dollar coverage would not only improve access to prescription …

Spurred by a desire to improve quality of care and to understand the relative value of
medical treatments, there has been a recent surge of interest in publicly funded comparative …